Christian Gege

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Emergency Department

Molecular Docking

Herpes Simplex Virus

Top Venues

Expert opinion on therapeutic patents

Science translational medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Gege, Gerald Kleymann
Helicase-primase inhibitors for the treatment of herpes simplex virus infections - patent evaluation of WO2023/225162 from gilead sciences inc. Expert opinion on therapeutic patents (2024)
Christian Gege, Friedrich Hahn, Christina Wangen, Sigrun Häge, Alexandra Herrmann, Nadja Uhlig, Valentina Eberlein, Leila Issmail, Robert Klopfleisch, Thomas Grunwald, Manfred Marschall, Hella Kohlhof, Daniel Vitt
Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 Activity. ChemMedChem (2024)
Christian Gege, Fernando J Bravo, Nadja Uhlig, Timo Hagmaier, Rosanne Schmachtenberg, Julia Elis, Anke Burger-Kentischer, Doris Finkelmeier, Klaus Hamprecht, Thomas Grunwald, David I Bernstein, Gerald Kleymann
A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections. Science translational medicine 13 (598) (2021)
Fabian Mayr, Gabriele Möller, Ulrike Garscha, Jana Fischer, Patricia Rodríguez Castaño, Silvia G Inderbinen, Veronika Temml, Birgit Waltenberger, Stefan Schwaiger, Rolf W Hartmann, Christian Gege, Stefan Martens, Alex Odermatt, Amit V Pandey, Oliver Werz, Jerzy Adamski, Hermann Stuppner, Daniela Schuster
Finding New Molecular Targets of Familiar Natural Products Using In Silico Target Prediction. International journal of molecular sciences 21 (19) (2020)